Vident Investment Advisory’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-150,259
| Closed | -$2.64M | – | 1260 |
|
|
2021
Q3 | $2.64M | Sell |
150,259
-10,732
| -7% | -$188K | 0.08% | 278 |
|
|
2021
Q2 | $1.56M | Buy |
160,991
+24,206
| +18% | +$235K | 0.05% | 503 |
|
|
2021
Q1 | $1.47M | Buy |
136,785
+1,006
| +0.7% | +$10.8K | 0.05% | 501 |
|
|
2020
Q4 | $2M | Sell |
135,779
-36,366
| -21% | -$535K | 0.08% | 283 |
|
|
2020
Q3 | $2.45M | Sell |
172,145
-4,955
| -3% | -$70.4K | 0.12% | 156 |
|
|
2020
Q2 | $1.43M | Buy |
+177,100
| New | +$1.43M | 0.08% | 342 |
|